home / stock / rvnc / rvnc news

RVNC News and Press, Revance Therapeutics Inc. From 02/22/22

Stock Information
Company Name: Revance Therapeutics Inc.
Stock Symbol: RVNC
Market: NASDAQ
Website: revance.com
Menu
RVNC RVNC Quote RVNC Short RVNC News RVNC Articles RVNC Message Board
Get RVNC Alerts

News, Short Squeeze, Breakout and More Instantly...
RVNC - Revance to Release Fourth Quarter and Full Year 2021 Financial Results on Monday, February 28, 2022

Conference Call Scheduled for Monday, February 28, 2022 at 4:30 p.m. ET. Revance Therapeutics, Inc. (Nasdaq: RVNC), a commercial stage biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that the company will release fourth quarte...
RVNC - RVNC DEADLINE TOMORROW: Hagens Berman, National Trial Attorneys, Encourages Revance Therapeutics (RVNC) Investors with Significant Losses to Contact Firm's Attorneys Now

SAN FRANCISCO, CA / ACCESSWIRE / February 7, 2022 / Hagens Berman urges Revance Therapeutics, Inc. (NASDAQ:RVNC) investors to with significant losses to submit your losses now . Class Period: Nov. 25, 2019 - Oct. 11, 2021 Lead Plaintiff Deadline: Feb. 8, 2022 Visit: www.hbsslaw.co...

RVNC - Kessler Topaz Meltzer & Checker, LLP: Final Deadline Reminder for Revance Therapeutics, Inc. (RVNC) Investors

Radnor, Pennsylvania--(Newsfile Corp. - February 3, 2022) -  The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed against Revance Therapeutics, Inc. ("Revance") (NASDAQ: RVNC). The action charges ...

RVNC - RVNC 6-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Revance Therapeutics (RVNC) Investors with Significant Losses to Contact Firm's Attorneys Before Feb. 8th

SAN FRANCISCO, CA / ACCESSWIRE / February 2, 2022 / Hagens Berman urges Revance Therapeutics, Inc. (NASDAQ:RVNC) investors to with significant losses to submit your losses now . Class Period: Nov. 25, 2019 - Oct. 11, 2021 Lead Plaintiff Deadline: Feb. 8, 2022 Visit: www.hbsslaw.co...
RVNC - HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Revance Therapeutics (RVNC) Investors to Lead Plaintiff Opportunity in Securities Case

SAN FRANCISCO, CA / ACCESSWIRE / January 25, 2022 / Hagens Berman urges Revance Therapeutics, Inc. (NASDAQ:RVNC) investors to with significant losses to submit your losses now . Class Period: Nov. 25, 2019 - Oct. 11, 2021 Lead Plaintiff Deadline: Feb. 8, 2022 Visit: www.hbsslaw....

RVNC - Revance Receives Clarity on Path to Resubmission of the BLA for DaxibotulinumtoxinA for Injection Following Type A Meeting with FDA

Complete response requires qualification of new working cell bank (WCB), which is in progress The FDA stated that a reinspection of the company’s manufacturing facility will be necessary prior to approval Revance Therapeutics, Inc. (Nasdaq: RVNC), a commer...

RVNC - Revance Provides Preliminary Fourth Quarter and Full Year 2021 Financial Results and a Corporate Update

Preliminary unaudited Q4 RHA® Collection revenue of between $23.0 million and $24.0 million Preliminary unaudited cash, cash equivalents, and short-term investments of approximately $225 million as of December 31 Preliminary unaudited full year GAAP and Non-...
RVNC - RVNC DEADLINE REMINDER: Kessler Topaz Meltzer & Check, LLP - Important LP February 8, 2022 Deadline Reminder for Revance Therapeutics, Inc.

RVNC DEADLINE REMINDER: Kessler Topaz Meltzer & Check, LLP - Important LP February 8, 2022 Deadline Reminder for Revance Therapeutics, Inc. RVNC DEADLINE REMINDER: Kessler Topaz Meltzer & Check, LLP - Important LP February 8, 2022 Deadline Reminder for Revance Therapeuti...

RVNC - SmileDirect Club Stock Isn't Making a Comeback Any Time in the Near Future

InvestorPlace - Stock Market News, Stock Advice & Trading Tips SmileDirect Club (NASDAQ: SDC ) stock is built around orthodontic services using clear plastic retainers. It’s a growing market. Source: Helen89 / Shutterstock.com SmileDirect showed it was no longer grow...

RVNC - Revance Therapeutics Deadline Alert

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Revance Therapeutics To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - December 13, 2021) - Faruqi & Faruqi, LLP, a leading national securi...
Previous 10 Next 10